Ponesimod
CAS号 | 854107-55-4 | 货号 | BCP17902 |
中文名 | Ponesimod | ||
英文名 | Ponesimod | ||
中文别名 | |||
英文别名 | ACT-128800; | ||
分子式 | C23H25ClN2O4S | 分子量 | 460.97 |
生物活性 | Ponesimod, also known as ACT-128800, is a potent, and orally active selective S1P(1) agonist. Ponesimod activated S1P(1)-mediated signal transduction with high potency (EC(50) of 5.7 nM) and selectivity. Ponesimod prevented edema formation, inflammatory cell accumulation, and cytokine release in the skin of mice with delayed-type hypersensitivity. Ponesimod also prevented the increase in paw volume and joint inflammation in rats with adjuvant-induced arthritis. Ponesimod may represent a new therapeutic approach in lymphocyte-mediated autoimmune diseases. | ||
信号通路 | GPCR/G Protein | ||
靶 点 | S1P Receptor |
结构式
本页面部分数据来自于公开的网络资源,所以瀚香生物不能保证其准确性。
不同批次的产品详情请咨询我们的客服:
- 全国免费电话:400-099-8200
瀚香生物(Biochempartner) 的所有产品和服务仅用于科学研究,禁止用于人体和治疗!